Rob Dillard

DocwireNews

<p>Providing COVID-19 vaccine educational messaging platforms in emergency departments (EDs) increases vaccine acceptance and uptake in unvaccinated patients, particularly in underserved communities, according to a new study published in <em>JAMA Internal Medicine.</em><p>COVID resulted in more than 1 million deaths in the US as of May 2022, and it is estimated that 58% of these deaths could have been prevented by timely COVID vaccination. Despite the robust efficacy of COVID vaccines, almost a quarter of the US population remains vaccine hesitant.</p><h2>Underserved Communities Need to Be Reached</h2><p>Minority groups like African Americans and Latinx persons are at a higher risk for poor outcomes from COVID infection, and EDs are positioned to serve as critical intervention sites for these communities. A previous analysis showed that patients whose primary care occurs in EDs had a higher rate of vaccine hesitancy than patients treated with primary care. As a result of this disparity, researchers conducted in-depth interviews of 65 ED patients with vaccine hesitancy whose primary care took place in EDs during the summer and fall of 2021. They used the results to construct the ED population-specific Promotion of COVID-19 Va(X)ccination in the Emergency Department (PROCOVAXED) messaging platforms &ndash; a series of messaging initiatives consisting of videos, informational flyers, and scripts for face-to-face messaging &ndash; in an effort to improve vaccine uptake.</p><p>In this analysis, the aforementioned 3-pronged COVID vaccine messaging platforms were delivered during patient waiting times. The two primary outcomes of interest were stipulated as COVID-19 vaccine acceptance, assessed by survey responses in the ED, and receipt of a COVID-19 vaccine within 30 days. In total, 496 participants were enrolled (221 during interventional weeks, and 275 during control weeks of no messaging).</p><h2>A Successful Intervention</h2><p>The results of the study found that delivery of COVID-19 vaccine messaging platforms resulted in appreciably higher vaccine acceptance among intervention group participants compared with the control group (25.8% vs 12.0%) as well as uptake within 30 days (20% vs 8.7%). The impact of the intervention was greater in Latinx persons and participants without primary care physicians.</p><p>&ldquo;Results of this cluster randomized clinical trial showed that with low NNT (number needed to treat), implementation of COVID-19 vaccine messaging platforms in EDs leads to greater vaccine acceptance and uptake in unvaccinated ED patients,&rdquo; the researchers concluded. They added that broad implementation (of messaging) in EDs &ldquo;could lead to greater COVID-19 vaccine delivery to underserved populations whose primary health care access occurs in EDs.&rdquo;</p><p>&nbsp;</p><p>&nbsp;</p></p>


Jordana Jampel

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Eric Bergson, MD

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Sara Nunnery, MD, MSCI

Trastuzumab Deruxtecan in HER2-Low Breast Cancer: Who’s the Right Patient?

HER2 Breast Cancer

Latest News

Educational Messaging Increases COVID-19 Vaccine Acceptance and Uptake

COVID-19

Providing COVID-19 vaccine educational messaging platforms in emergency departments (EDs) increases vaccine acceptance and uptake in unvaccinated patients, particularly in ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe